Central IGF-I Receptors in the Brain Are Instrumental to Neuroprotection by Systemically Injected IGF-I in a Rat Model for Ischemic Stroke

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2016 Apr 16

PMID 27080541

Citations 18

Authors

Deborah De Geyter

Ann De Smedt

Wendy Stoop

Jacques De Keyser

Ron Kooijman

Affiliations

Soon will be listed here.

Abstract

Aim: Insulin-like growth factor I (IGF-I) is a neuroprotective agent in animal models of ischemic stroke. The purpose of this study was to determine whether systemically injected IGF-I exerts its neuroprotective action by binding to IGF-I receptors in the brain after crossing the blood-brain barrier, or via peripheral effects.

Methods: To differentiate the central effects of IGF-I from systemic effects, ischemic stroke was induced in conscious male Wistar Kyoto rats by the injection of endothelin-1 adjacent to the middle cerebral artery in the right hemisphere, while either the IGF-I receptor antagonist JB-1 or vehicle was introduced into the right lateral ventricle.

Results: Intravenous injection of recombinant human (rh)IGF-I resulted in 50% reduction in infarct size, which was counteracted by the central administration of JB-1. Furthermore, rhIGF-I was detected in both the ischemic and nonischemic hemisphere.

Conclusions: Systemically injected rhIGF-I passes the blood-brain barrier and protects neurons via IGF-I receptors in the brain in rats with an ischemic stroke.

Citing Articles

Scp776, A Novel IGF-1 Fusion Protein for Acute Therapy to Promote Escape From Apoptosis in Tissues Affected by Ischemic Injury: 2 Randomized Placebo-Controlled Phase 1 Studies in Healthy Adults.

Pfaff S, OReilly T, Zhang Y, Olsen W, Kuchenbecker K Clin Pharmacol Drug Dev. 2024; 14(1):65-78.

PMID: 39648632 PMC: 11701966. DOI: 10.1002/cpdd.1486.

Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach.

Hu B, Pei J, Wan C, Liu S, Xu Z, Zou Y J Inflamm Res. 2024; 17:4625-4646.

PMID: 39045531 PMC: 11264385. DOI: 10.2147/JIR.S461427.

IGF-1's protective effect on OSAS rats' learning and memory.

Zeng L, Yu T, Liu H, Li M, Wang J, Wang C Sleep Breath. 2024; 28(5):1919-1928.

PMID: 38858326 PMC: 11450044. DOI: 10.1007/s11325-024-03047-8.

A role for astrocytic insulin-like growth factor I receptors in the response to ischemic insult.

Suda K, Pignatelli J, Genis L, Fernandez A, de Sevilla E, de la Cruz I J Cereb Blood Flow Metab. 2023; 44(6):970-984.

PMID: 38017004 PMC: 11318401. DOI: 10.1177/0271678X231217669.

Insulin-like growth factor 1 in heat stress-induced neuroinflammation: novel perspective about the neuroprotective role of chromium.

Wang S, Hou K, Gui S, Ma Y, Wang S, Zhao S Stress Biol. 2023; 3(1):23.

PMID: 37676529 PMC: 10441889. DOI: 10.1007/s44154-023-00105-1.

References

Reinhardt R, Bondy C . Insulin-like growth factors cross the blood-brain barrier. Endocrinology. 1994; 135(5):1753-61. DOI: 10.1210/endo.135.5.7525251. View

Van Hemelrijck A, Vermijlen D, Hachimi-Idrissi S, Sarre S, Ebinger G, Michotte Y . Effect of resuscitative mild hypothermia on glutamate and dopamine release, apoptosis and ischaemic brain damage in the endothelin-1 rat model for focal cerebral ischaemia. J Neurochem. 2003; 87(1):66-75. DOI: 10.1046/j.1471-4159.2003.01977.x. View

Heck S, Lezoualch F, Engert S, Behl C . Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB. J Biol Chem. 1999; 274(14):9828-35. DOI: 10.1074/jbc.274.14.9828. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Aberg D, Jood K, Blomstrand C, Jern C, Nilsson M, Isgaard J . Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. J Clin Endocrinol Metab. 2011; 96(7):E1055-64. DOI: 10.1210/jc.2010-2802. View

Bolos M, Fernandez S, Torres-Aleman I . Oral administration of a GSK3 inhibitor increases brain insulin-like growth factor I levels. J Biol Chem. 2010; 285(23):17693-700. PMC: 2878533. DOI: 10.1074/jbc.M109.096594. View

Clinckers R, Smolders I, Michotte Y, Ebinger G, Danhof M, Voskuyl R . Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain. Br J Pharmacol. 2008; 155(7):1127-38. PMC: 2597256. DOI: 10.1038/bjp.2008.366. View

Ginsberg M, Busto R . Rodent models of cerebral ischemia. Stroke. 1989; 20(12):1627-42. DOI: 10.1161/01.str.20.12.1627. View

Rizk N, Myatt-Jones J, Rafols J, Dunbar J . Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats. Endocrine. 2007; 31(1):66-71. DOI: 10.1007/s12020-007-0012-0. View

10.

De Smedt A, Brouns R, Uyttenboogaart M, De Raedt S, Moens M, Wilczak N . Insulin-like growth factor I serum levels influence ischemic stroke outcome. Stroke. 2011; 42(8):2180-5. DOI: 10.1161/STROKEAHA.110.600783. View

11.

Kovac A, Erickson M, Banks W . Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation. 2011; 8:139. PMC: 3207972. DOI: 10.1186/1742-2094-8-139. View

12.

De Geyter D, Stoop W, Sarre S, De Keyser J, Kooijman R . Neuroprotective efficacy of subcutaneous insulin-like growth factor-I administration in normotensive and hypertensive rats with an ischemic stroke. Neuroscience. 2013; 250:253-62. DOI: 10.1016/j.neuroscience.2013.07.016. View

13.

Frank H, Pardridge W, Morris W, Rosenfeld R, Choi T . Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels. Diabetes. 1986; 35(6):654-61. DOI: 10.2337/diab.35.6.654. View

14.

Oztas B, Kucuk M, Sandalci U . Effect of insulin-induced hypoglycemia on blood-brain barrier permeability. Exp Neurol. 1985; 87(1):129-36. DOI: 10.1016/0014-4886(85)90139-6. View

15.

Wang Y, Chen C, Lin S, Chuang Y, Sheu W, Tung K . Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia. Mol Cell Endocrinol. 2013; 367(1-2):50-6. DOI: 10.1016/j.mce.2012.12.016. View

16.

Pietrzkowski Z, Wernicke D, Porcu P, Jameson B, Baserga R . Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. Cancer Res. 1992; 52(23):6447-51. View

17.

Liu X, Fawcett J, Hanson L, Frey 2nd W . The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats. J Stroke Cerebrovasc Dis. 2007; 13(1):16-23. DOI: 10.1016/j.jstrokecerebrovasdis.2004.01.005. View

18.

Shibata M, Yamada S, Kumar S, Calero M, Bading J, Frangione B . Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest. 2000; 106(12):1489-99. PMC: 387254. DOI: 10.1172/JCI10498. View

19.

Dietrich W, Alonso O, Busto R . Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke. 1993; 24(1):111-6. DOI: 10.1161/01.str.24.1.111. View

20.

Paxinos G, Watson C, Emson P . AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods. 1980; 3(2):129-49. DOI: 10.1016/0165-0270(80)90021-7. View